✦ LIBER ✦

Salvage treatment with erlotinib after gefitinib failure in advanced non-small-cell lung cancer patients with poor performance status: A matched-pair case–control study

✍ Scribed by Daxian Luo; Meijuan Huang; Xinxing Zhang; Min Yu; Bingwen Zou; Yanying Li; Jianlin Long; Jin Wang; Feng Peng; Yong Xu; Lu Li; Li Ren; Mei Hou; You Lu

Book ID: 114935408
Publisher: Wiley (Blackwell Publishing)
Year: 2012
Tongue: English
Weight: 289 KB
Volume: 3
Category: Article
ISSN: 1759-7706
DOI: 10.1111/j.1759-7714.2011.00087.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel as salvage chemotherapy in pat

Docetaxel as salvage chemotherapy in patients with advanced non-small cell lung cancer after failure of cytotoxic agents and gefitinib treatment

✍ Yilong Wu; Jinji Yang; Yujuan Huang; Qin Zhou; Yisheng Huang; Chongrui Xu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 545 KB

6625 POSTER Gefitinib (G) treatment outc

6625 POSTER Gefitinib (G) treatment outcome after progression on erlotinib (E) in patients with advanced non-small-cell lung cancer (NSCLC)

✍ Grossi, F.; Brianti, A.; Defferrari, C.; Dal Bello, M.G.; Loprevite, M.; Catania 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Single-Agent Gefitinib in Patients with

Single-Agent Gefitinib in Patients with Untreated Advanced Non–Small-Cell Lung Cancer and Poor Performance Status: A Minnie Pearl Cancer Research Network Phase II Trial

✍ David R. Spigel; John D. Hainsworth; Emily R. Burkett; Howard A. Burris; Denise 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 519 KB

Phase I study of continuous afatinib (BI

Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4)

✍ H. Murakami; T. Tamura; T. Takahashi; H. Nokihara; T. Naito; Y. Nakamura; K. Nis 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 338 KB

Paclitaxel Poliglumex/Carboplatin Is Sim

Paclitaxel Poliglumex/Carboplatin Is Similar to Paclitaxel/Carboplatin as First-Line Treatment in Elderly Patients with Advanced Non–Small-Cell Lung Cancer and a Poor Performance Status

✍ G. Kesava Reddy; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 459 KB

A Randomized Phase II Study of Sorafenib

A Randomized Phase II Study of Sorafenib/Gemcitabine or Sorafenib/Erlotinib for Advanced Non–Small-Cell Lung Cancer in Elderly Patients or Patients with a Performance Status of 2: Treatment Rationale and Protocol Dynamics

✍ Cesare Gridelli; Antonio Rossi; Floriana Mongillo; Maria Bareschino; Paolo Maion 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB